Drug Information

Drug General Information
Drug ID
D06QFO
Former ID
DNC004861
Drug Name
(5-(pyridin-3-yl)furan-2-yl)methanamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528540]
Formula
C10H10N2O
Canonical SMILES
C1=CC(=CN=C1)C2=CC=C(O2)CN
InChI
1S/C10H10N2O/c11-6-9-3-4-10(13-9)8-2-1-5-12-7-8/h1-5,7H,6,11H2
InChIKey
LENAVORGWBTPJR-UHFFFAOYSA-N
PubChem Compound ID
11332763
Target and Pathway
Target(s) Cytochrome P450 2D6 Target Info Inhibitor [528540]
KEGG Pathway Metabolism of xenobiotics by cytochrome P450
Drug metabolism - cytochrome P450
Serotonergic synapse
Reactome Xenobiotics
WikiPathways Metapathway biotransformation
Tamoxifen metabolism
Oxidation by Cytochrome P450
Vitamin D Receptor Pathway
Aripiprazole Metabolic Pathway
Fatty Acid Omega Oxidation
Codeine and Morphine Metabolism
References
Ref 528540J Med Chem. 2006 Nov 30;49(24):6987-7001.Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.
Ref 528540J Med Chem. 2006 Nov 30;49(24):6987-7001.Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.